Dedicare Future Growth
Future criteria checks 3/6
Dedicare is forecast to grow earnings and revenue by 6.1% and 5.6% per annum respectively. EPS is expected to grow by 6.2% per annum. Return on equity is forecast to be 28.6% in 3 years.
Key information
6.1%
Earnings growth rate
6.2%
EPS growth rate
Healthcare earnings growth | 21.0% |
Revenue growth rate | 5.6% |
Future return on equity | 28.6% |
Analyst coverage | Low |
Last updated | 13 Feb 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,241 | 115 | 117 | 132 | 1 |
12/31/2025 | 2,153 | 108 | 110 | 124 | 1 |
12/31/2024 | 2,070 | 103 | 68 | 129 | 1 |
3/31/2024 | 1,900 | 96 | 121 | 125 | N/A |
12/31/2023 | 1,973 | 110 | 141 | 145 | N/A |
9/30/2023 | 2,011 | 102 | 167 | 172 | N/A |
6/30/2023 | 1,937 | 102 | 113 | 118 | N/A |
3/31/2023 | 1,882 | 105 | 120 | 126 | N/A |
12/31/2022 | 1,772 | 101 | 100 | 105 | N/A |
9/30/2022 | 1,623 | 93 | 40 | 45 | N/A |
6/30/2022 | 1,504 | 84 | 69 | 73 | N/A |
3/31/2022 | 1,379 | 76 | 74 | 78 | N/A |
12/31/2021 | 1,250 | 66 | 67 | 70 | N/A |
9/30/2021 | 1,143 | 61 | 52 | 54 | N/A |
6/30/2021 | 1,063 | 55 | 45 | 47 | N/A |
3/31/2021 | 980 | 42 | 35 | 37 | N/A |
12/31/2020 | 885 | 36 | 38 | 40 | N/A |
9/30/2020 | 823 | 29 | 64 | 66 | N/A |
6/30/2020 | 783 | 23 | 60 | 62 | N/A |
3/31/2020 | 762 | 26 | 46 | 47 | N/A |
12/31/2019 | 776 | 26 | 45 | 47 | N/A |
9/30/2019 | 784 | 28 | 25 | 28 | N/A |
6/30/2019 | 794 | 31 | 40 | 42 | N/A |
3/31/2019 | 803 | 32 | 34 | 38 | N/A |
12/31/2018 | 812 | 38 | 14 | 19 | N/A |
9/30/2018 | 812 | 42 | 21 | 25 | N/A |
6/30/2018 | 787 | 43 | 26 | 29 | N/A |
3/31/2018 | 778 | 50 | 59 | 60 | N/A |
12/31/2017 | 785 | 60 | N/A | 82 | N/A |
9/30/2017 | 781 | 68 | N/A | 80 | N/A |
6/30/2017 | 759 | 72 | N/A | 71 | N/A |
3/31/2017 | 716 | 65 | N/A | 48 | N/A |
12/31/2016 | 650 | 53 | N/A | 35 | N/A |
9/30/2016 | 603 | 42 | N/A | 35 | N/A |
6/30/2016 | 585 | 33 | N/A | 38 | N/A |
3/31/2016 | 573 | 30 | N/A | 28 | N/A |
12/31/2015 | 573 | 30 | N/A | 22 | N/A |
9/30/2015 | 567 | 31 | N/A | 26 | N/A |
6/30/2015 | 548 | 31 | N/A | 22 | N/A |
3/31/2015 | 523 | 28 | N/A | 28 | N/A |
12/31/2014 | 498 | 23 | N/A | 46 | N/A |
9/30/2014 | 482 | 17 | N/A | 28 | N/A |
6/30/2014 | 468 | 14 | N/A | 20 | N/A |
3/31/2014 | 467 | 13 | N/A | 19 | N/A |
12/31/2013 | 469 | 14 | N/A | -5 | N/A |
9/30/2013 | 486 | 15 | N/A | 20 | N/A |
6/30/2013 | 507 | 17 | N/A | 18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CL6's forecast earnings growth (6.1% per year) is above the savings rate (0.7%).
Earnings vs Market: CL6's earnings (6.1% per year) are forecast to grow slower than the German market (18.6% per year).
High Growth Earnings: CL6's earnings are forecast to grow, but not significantly.
Revenue vs Market: CL6's revenue (5.6% per year) is forecast to grow faster than the German market (5.2% per year).
High Growth Revenue: CL6's revenue (5.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CL6's Return on Equity is forecast to be high in 3 years time (28.6%)